sdz mrl 953 has been researched along with Bacterial Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aschauer, H; Hildebrandt, J; Lam, C; Liehl, E; Macher, I; Schütze, E; Stütz, P | 1 |
1 other study(ies) available for sdz mrl 953 and Bacterial Infections
Article | Year |
---|---|
SDZ MRL 953, a novel immunostimulatory monosaccharidic lipid A analog with an improved therapeutic window in experimental sepsis.
Topics: Animals; Anti-Infective Agents; Bacterial Infections; Drug Interactions; Female; Galactosamine; Humans; Lethal Dose 50; Lipid A; Lipopolysaccharides; Mice; Mice, Inbred C57BL | 1991 |